about
MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3' untranslated regionA novel POK family transcription factor, ZBTB5, represses transcription of p21CIP1 geneVascular endothelial growth factor (VEGF) signaling regulates hippocampal neurons by elevation of intracellular calcium and activation of calcium/calmodulin protein kinase II and mammalian target of rapamycinA modified hTERT promoter-directed oncolytic adenovirus replication with concurrent inhibition of TGFbeta signaling for breast cancer therapyThe WNT antagonist Dickkopf2 promotes angiogenesis in rodent and human endothelial cells.A proteoliposome containing apolipoprotein A-I mutant (V156K) enhances rapid tumor regression activity of human origin oncolytic adenovirus in tumor-bearing zebrafish and mice.ZBTB2, a novel master regulator of the p53 pathway.Generation of a rabbit V(H) domain antibody polyspecific to c-Met and adenoviral knob protein.Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL.Role of promyelocytic leukemia zinc finger (PLZF) in cell proliferation and cyclin-dependent kinase inhibitor 1A (p21WAF/CDKN1A) gene repression.Identification and functional characterization of nuclear mortalin in human carcinogenesis.A novel sLRP6E1E2 inhibits canonical Wnt signaling, epithelial-to-mesenchymal transition, and induces mitochondria-dependent apoptosis in lung cancer.Gene therapy using hepatocyte growth factor expressing adenovirus improves skin flap survival in a rat model.Safety profiles and antitumor efficacy of oncolytic adenovirus coated with bioreducible polymer in the treatment of a CAR negative tumor modelActive targeting of RGD-conjugated bioreducible polymer for delivery of oncolytic adenovirus expressing shRNA against IL-8 mRNA.Molecular characterization of apoptosis induced by CARF silencing in human cancer cellsOptimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF.Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα.Functional significance of point mutations in stress chaperone mortalin and their relevance to Parkinson disease.Development of porous PLGA/PEI1.8k biodegradable microspheres for the delivery of mesenchymal stem cells (MSCs).Adenovirus expressing dual c-Met-specific shRNA exhibits potent antitumor effect through autophagic cell death accompanied by senescence-like phenotypes in glioblastoma cellspH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesisTTAC-0001, a human monoclonal antibody targeting VEGFR-2/KDR, blocks tumor angiogenesis.Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials.Targeting delivery of tocopherol and doxorubicin grafted-chitosan polymeric micelles for cancer therapy: In vitro and in vivo evaluation.Soluble vascular endothelial growth factor decoy receptor FP3 exerts potent antiangiogenic effectsStress chaperone mortalin regulates human melanogenesis.Heat Shock Protein 90 Inhibitor Decreases Collagen Synthesis of Keloid Fibroblasts and Attenuates the Extracellular Matrix on the Keloid Spheroid Model.Polymeric oncolytic adenovirus for cancer gene therapy.Hepatoma targeting peptide conjugated bio-reducible polymer complexed with oncolytic adenovirus for cancer gene therapySystemic Delivery of an Oncolytic Adenovirus Expressing Decorin for the Treatment of Breast Cancer Bone MetastasesAnionic clay as the drug delivery vehicle: tumor targeting function of layered double hydroxide-methotrexate nanohybrid in C33A orthotopic cervical cancer modelA vesicular stomatitis virus glycoprotein epitope-incorporated oncolytic adenovirus overcomes CAR-dependency and shows markedly enhanced cancer cell killing and suppression of tumor growth.Effects of Human Mesenchymal Stem Cells Transduced with Superoxide Dismutase on Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice.Regulation of the cyclin-dependent kinase inhibitor 1A gene (CDKN1A) by the repressor BOZF1 through inhibition of p53 acetylation and transcription factor Sp1 binding.RGD peptide-modified adenovirus expressing hepatocyte growth factor and X-linked inhibitor of apoptosis improves islet transplantation.Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.Oncolytic adenovirus expressing IL-23 and p35 elicits IFN-γ- and TNF-α-co-producing T cell-mediated antitumor immunity.Distinct roles of DKK1 and DKK2 in tumor angiogenesis.Inorganic nanovehicle targets tumor in an orthotopic breast cancer model.
P50
Q24635277-53A8C36A-11DE-43BB-AFB8-22B8602F24AEQ28119188-121B82E2-AC71-4518-9D8C-E468701E9F03Q28568769-50A726F6-56E5-4D87-9CE5-AF1A24A01D30Q30434613-31E9A4F8-FC49-4F76-8490-FF9BDF4B001DQ30499919-132AD8E6-2CF0-4060-8C09-670EC6D94A1BQ30564011-3B60B434-551B-4FB5-B0F3-D12E95049E4CQ31814767-5BD3802F-0741-4A1A-A381-596CBB7009F0Q33227537-D9AB5479-60E0-43EF-95A7-9A1B4FAD76D8Q33730717-FC318D7E-8210-42D1-A295-9EEFCD9D8F75Q33846387-C497E693-29CA-4C35-9C03-292E07FDB384Q34138936-5792984D-823E-4B80-A9B7-5329261CBC98Q34273617-BBE620BF-5ED1-4C68-A1A3-80DA6BBED35BQ34588837-3CBDC9FB-DF72-4B12-94CB-C23536B602AFQ34959758-6FED4E1B-CAF9-461F-BAA0-29E0C8CE68FAQ35000513-7B5207F6-A789-4B9C-A416-CB83B99FED89Q35092634-0C9218B8-B993-448C-B87E-48026B534ABCQ35144428-239F2AC8-FDF0-4609-B61B-E974E37E2ABEQ35204881-9B5E05B0-8E85-421F-A1B1-243BC83A91B5Q35221600-9FD8CF2E-C36C-4988-86AE-12CAD1EFE225Q35395603-2CEE341C-2FB4-42AF-A91B-49463B000B64Q35551938-00FF2423-A0A9-4641-A0ED-DC8D026A2CE7Q35569909-425F3039-6E67-4840-87FB-74F83F0192D7Q35622461-8737D197-758E-41B0-8857-357D4F74E981Q35624010-11325D8D-0EE3-43DF-8FCA-44C2260BE05AQ35676336-AFC3834C-2790-4FAA-8950-887E9FB16A0BQ35939433-466BEAB5-B406-431E-9355-0DB361FF5CA2Q35983240-EC2899BD-2291-408C-869A-D6AC1B4A8C9EQ36015442-CEF7C6D7-0EFE-4519-99AC-2E6E0D2A6A8DQ36344901-38C611C1-C676-43BA-A6C4-988C7B380074Q36395971-7E25122F-5C1C-4A0F-AA75-9E1295348C0EQ36406892-AF4AC0DE-810C-47C4-A52B-9E96A67305B6Q36498730-FE2455B6-8348-4ABE-99A1-915F83E1032CQ36544244-8F86051B-C9C3-446B-8D41-9C9741A8FBAAQ36580091-209A2671-CDA0-45CB-9360-C85D3D20594DQ36666178-0E35AA71-C18D-407F-9C8A-9014CC54D667Q36791710-AC6468B0-11FA-48CC-B650-D5B83943BE86Q36879787-D4D0A736-69A2-487A-8B80-700B632FF09AQ36981396-EC17DA4C-7AF1-4C97-B66C-1EB9E36F7BBFQ37501863-F23A7B1E-8023-4E97-A19D-124148844688Q37653482-2D80D23A-8FFF-4F2B-8C5B-3187EED2CC85
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Chae-Ok Yun
@ast
Chae-Ok Yun
@en
Chae-Ok Yun
@es
Chae-Ok Yun
@nl
Chae-Ok Yun
@sl
type
label
Chae-Ok Yun
@ast
Chae-Ok Yun
@en
Chae-Ok Yun
@es
Chae-Ok Yun
@nl
Chae-Ok Yun
@sl
prefLabel
Chae-Ok Yun
@ast
Chae-Ok Yun
@en
Chae-Ok Yun
@es
Chae-Ok Yun
@nl
Chae-Ok Yun
@sl
P106
P1153
7101911535
P31
P496
0000-0002-9466-4531